Viewing Study NCT05735392


Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2025-12-29 @ 5:42 PM
Study NCT ID: NCT05735392
Status: COMPLETED
Last Update Posted: 2023-02-21
First Post: 2023-01-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial)
Sponsor: Consorzio Oncotech
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LiqERBcept View
None Trastuzumab emtansine View
None Liquid Biopsy View